SCHEMBL160641

SCHEMBL160641

O=C(O)C12CC3CC(C1)CC(C(=O)O)(C3)C2(C(=O)O)C(=O)O

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.35
CYP2C9 P11712 1/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
PKM P14618 1/20 0.35
EPHX1 P07099 1/20 0.34
EPHX2 P34913 1/20 0.34
POLB P06746 1/20 0.34
ALDH1A1 P00352 3/20 0.33
SMN1; SMN2 Q16637 2/20 0.32
LMNA P02545 1/20 0.32
GAA P10253 2/20 0.31
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
KDM4E B2RXH2 1/20 0.31
HTT P42858 1/20 0.31
TSHR P16473 1/20 0.30
HSD11B1 P28845 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31065066 0.98 THRB (0.34) THRBCYP2C9L3MBTL1PKMEPHX1
SCHEMBL31065065 0.98 THRB (0.34) THRBCYP2C9L3MBTL1PKMEPHX1
SCHEMBL22092713 0.86 L3MBTL1 (0.36) L3MBTL1PKMALDH1A1SMN1; SMN2LMNA
SCHEMBL513114 0.85 CYP2C9 (0.38) THRBCYP2C9L3MBTL1PKMPOLB
SCHEMBL1072980 0.78 ALDH1A1 (0.36) THRBCYP2C9L3MBTL1PKMEPHX1
SCHEMBL1375251 0.76
SCHEMBL471870 0.73
SCHEMBL702569 0.73 ALDH1A1 (0.33) THRBCYP2C9L3MBTL1PKMEPHX1
SCHEMBL14246423 0.73 ALDH1A1 (0.33) THRBCYP2C9L3MBTL1PKMEPHX1
SCHEMBL4889920 0.72 ALDH1A1 (0.33) THRBCYP2C9L3MBTL1PKMPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 573 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025238576-A1 SYSTEM AND METHOD FOR STORING LIQUIDS HAVING LOW LATENT HEAT OF VAPORIZATION Nuovo Pignone Tecnologie – S.r.l. (IT) 2025-11-20 WO claimed
US-20250354659-A1 SYSTEM AND METHOD FOR STORING LIQUIDS HAVING LOW LATENT HEAT OF VAPORIZATION NUOVO PIGNONE TECNOLOGIE – S R L (IT) 2025-11-20 US claimed
US-12397489-B2 Methods of making metal-organic framework extrudates ExxonMobil Technology and Engineering Company (US) 2025-08-26 US claimed
EP-4598672-A1 HYBRID ADSORBENT GRANULES AND FILTERS MADE WITH THE GRANULES Numat Technologies Inc. (US) 2025-08-13 EP claimed
CN-119978737-A High-wear-resistance PET modified material and preparation method thereof 苏州德丽雅新材料科技有限公司 2025-05-13 CN claimed
EP-4526587-A2 LIQUEFIED GAS SYSTEM WITH BOIL-OFF CAPTURE Numat Technologies Inc. (US) 2025-03-26 EP claimed
US-20240261758-A1 Spherical Metal-Organic Frameworks Using Alginate ExxonMobil Technology and Engineering Company 2024-08-08 US claimed
US-20240247002-A1 Flocculation and Rapid Filtration Of Metal Organic Frameworks ExxonMobil Technology and Engineering Company 2024-07-25 US claimed
WO-2024107531-A1 HYBRID ADSORBENT GRANULES AND FILTERS MADE WITH THE GRANULES NUMAT TECHNOLOGIES, INC (US) 2024-05-23 WO claimed
CN-117924581-A Electronic ink microcapsule wall, electronic paper ink microcapsule and preparation method thereof 深圳秋田微电子股份有限公司 2024-04-26 CN claimed
US-7179765-B2 Process for preparing hydrogen peroxide from the elements BASF AKTIENGESELLSCHAFT (DE) 2007-02-20 US claimed
WO-2006042169-A2 POLYMER-BASED TISSUE-ADHESIVE FOR MEDICAL USE E.I. DUPONT DE NEMOURS AND COMPANY (US) 2006-04-20 WO claimed
US-20060079599-A1 Polymer-based tissue-adhesive form medical use ACTAMAX SURGICAL MATERIALS, LLC 2006-04-13 US claimed
US-20060057057-A1 Process for preparing hydrogen peroxide from the elements BASF AKTIENGESELLSCHAFT (DE) 2006-03-16 US claimed
US-7008607-B2 Process for preparing hydrogen peroxide from the elements BASF AKTIENGESELLSCHAFT (DE) 2006-03-07 US claimed
EP-1494998-A2 MULTIPLE-COMPONENT SOLID PHASES CONTAINING AT LEAST ONE ACTIVE PHARMACEUTICAL INGREDIENT UNIVERSITY OF SOUTH FLORIDA (US) 2005-01-12 EP claimed
US-20040081611-A1 Process for preparing hydrogen peroxide from the elements BASF AKIENGESELLSCHAFT (DE) 2004-04-29 US claimed
US-6624318-B1 Process for the epoxidation of an organic compound with oxygen or an oxygen-delivering compounds using catalysts containing metal-organic frame-work materials BASF AKTIENGESELLSCHAFT (DE) 2003-09-23 US claimed
WO-2003074474-A2 MULTIPLE-COMPONENT SOLID PHASES CONTAINING AT LEAST ONE ACTIVE PHARMACEUTICAL INGREDIENT UNIVERSITY OF SOUTH FLORIDA (US) 2003-09-12 WO claimed
US-6617467-B1 Polymerizing carbon dioxide with an alkylene oxide in the presence of a catalytic framework material comprising pores and a metal ion with a bidentate organic compound coordinated to the ion BASF AKTIENGESELLSCHAFT (DE) 2003-09-09 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060079599-A1 Polymer-based tissue-adhesive form medical use ADSL, SI, VCAM1 THRB 2016/4885CYP2C9 1758/4885L3MBTL1 1684/4885
US-20240247002-A1 Flocculation and Rapid Filtration Of Metal Organic Frameworks FLOT1, HNRNPF, POF1B THRB 4679/4885CYP2C9 2993/4885L3MBTL1 2711/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.